Europe - FRA:QIA - NL0015002CX3 - Common Stock
Taking everything into account, QIA scores 6 out of 10 in our fundamental rating. QIA was compared to 19 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a decent growth rate and is not valued too expensively. These ratings could make QIA a good candidate for quality investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.41% | ||
ROE | 10.65% | ||
ROIC | 8.66% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 26.86% | ||
PM (TTM) | 18.3% | ||
GM | 64.18% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.25 | ||
Debt/FCF | 2.91 | ||
Altman-Z | 4.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.61 | ||
Quick Ratio | 1.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 20.48 | ||
Fwd PE | 18.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 20.97 | ||
EV/EBITDA | 14.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.53% |
FRA:QIA (10/17/2025, 3:37:04 PM)
41.17
-0.05 (-0.13%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 0.53% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 20.48 | ||
Fwd PE | 18.4 | ||
P/S | 5.1 | ||
P/FCF | 20.97 | ||
P/OCF | 15.41 | ||
P/B | 2.97 | ||
P/tB | 16.27 | ||
EV/EBITDA | 14.5 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 6.41% | ||
ROE | 10.65% | ||
ROCE | 11.67% | ||
ROIC | 8.66% | ||
ROICexc | 10.87% | ||
ROICexgc | 46.44% | ||
OM | 26.86% | ||
PM (TTM) | 18.3% | ||
GM | 64.18% | ||
FCFM | 24.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.25 | ||
Debt/FCF | 2.91 | ||
Debt/EBITDA | 1.2 | ||
Cap/Depr | 94.78% | ||
Cap/Sales | 8.78% | ||
Interest Coverage | 250 | ||
Cash Conversion | 91.61% | ||
Profit Quality | 132.83% | ||
Current Ratio | 1.61 | ||
Quick Ratio | 1.35 | ||
Altman-Z | 4.1 |